Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma

A Nakagawara1, K Ikeda, K Higashi

  • 1Department of Pediatric Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Surgery
|January 1, 1990
PubMed

Insights

Advanced neuroblastoma patients with lower N-myc gene copies showed higher urinary catecholamine levels. This suggests a link between N-myc amplification, catecholamine metabolism, and prognosis in neuroblastoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Neuroblastoma is a pediatric cancer often associated with N-myc gene amplification.
  • Catecholamine metabolism is frequently altered in neuroblastoma patients.
  • The interplay between N-myc status and catecholamine pathways is not fully understood.

Purpose of the Study:

  • To investigate the relationship between N-myc gene amplification and urinary catecholamine metabolite excretion in advanced neuroblastoma.
  • To determine if these factors influence patient prognosis.

Main Methods:

  • Studied 32 patients with advanced neuroblastoma (stages III-IV).
  • Measured urinary excretion of vanillylmandelic acid, homovanillic acid, noradrenaline, and dopamine before therapy.
  • Assessed N-myc gene amplification in primary tumors.

Main Results:

  • Patients with lower N-myc copies (1-10) had significantly higher urinary vanillylmandelic acid, homovanillic acid, and noradrenaline compared to those with >10 copies.
  • Urinary dopamine levels did not differ significantly between groups.
  • Higher urinary noradrenaline/dopamine ratio was observed in patients with lower N-myc copies.
  • N-myc amplification, urinary vanillylmandelic acid, and the noradrenaline/dopamine ratio were significant prognostic factors.

Conclusions:

  • An inverse regulatory mechanism between N-myc amplification and catecholamine metabolism may exist in advanced neuroblastoma.
  • This interaction likely influences patient prognosis.
  • Metabolic blockade from dopamine to noradrenaline is a potential key pathway.